Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase.

[1]  N. Kobayashi,et al.  In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs , 2016, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  Daan P. Geerke,et al.  Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation , 2015, PloS one.

[3]  Teresa Kaserer,et al.  In Silico Predictions of Drug – Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition – a Comparative Study of Virtual Screening Performance , 2015, Molecular informatics.

[4]  Yang Zhang,et al.  I-TASSER server: new development for protein structure and function predictions , 2015, Nucleic Acids Res..

[5]  C. Fernández-Llamazares,et al.  Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics? , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[6]  Z. Orgován,et al.  Catalytically distinct states captured in a crystal lattice: the substrate-bound and scavenger states of acylaminoacyl peptidase and their implications for functionality. , 2015, Acta crystallographica. Section D, Biological crystallography.

[7]  Yang Zhang,et al.  The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.

[8]  N. Kobayashi,et al.  Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid , 2011, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  Y. Masuo,et al.  Characterization of Inhibitory Effect of Carbapenem Antibiotics on the Deconjugation of Valproic Acid Glucuronide , 2010, Drug Metabolism and Disposition.

[10]  N. Kobayashi,et al.  Identification of Valproic Acid Glucuronide Hydrolase As a Key Enzyme for the Interaction of Valproic Acid with Carbapenem Antibiotics , 2010, Drug Metabolism and Disposition.

[11]  R. Sharan,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[12]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[13]  Takeshi Ishikawa,et al.  Theoretical study of the prion protein based on the fragment molecular orbital method , 2009, J. Comput. Chem..

[14]  A. Hoffman,et al.  Valproic Acid Plasma Concentration Decreases in a Dose‐Independent Manner Following Administration of Meropenem: A Retrospective Study , 2009, Journal of clinical pharmacology.

[15]  Takeshi Ishikawa,et al.  Fragment molecular orbital calculation using the RI-MP2 method , 2009 .

[16]  Sitao Wu,et al.  MUSTER: Improving protein sequence profile–profile alignments by using multiple sources of structure information , 2008, Proteins.

[17]  L. Polgár,et al.  The acylaminoacyl peptidase from Aeropyrum pernix K1 thought to be an exopeptidase displays endopeptidase activity. , 2007, Journal of molecular biology.

[18]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[19]  V. Fülöp,et al.  Crystallization and preliminary crystallographic analysis of porcine acylaminoacyl peptidase. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[20]  P. Hantson,et al.  Pharmacokinetic interaction between valproic acid and meropenem , 2005, Intensive Care Medicine.

[21]  J. Borrás-Blasco,et al.  Acute Seizures Due to a Probable Interaction between Valproic Acid and Meropenem , 2005, The Annals of pharmacotherapy.

[22]  Masahiro Nakamura,et al.  MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS , 2004, Drug Metabolism and Disposition.

[23]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[24]  H. Sağlam,et al.  Meropenem decreases serum level of valproic acid. , 2004, Pediatric neurology.

[25]  Jose Cosme,et al.  Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.

[26]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[27]  H. Naganuma,et al.  Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[28]  F. Camu,et al.  Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. , 1998, The Journal of antimicrobial chemotherapy.

[29]  A. Fujimura,et al.  Panipenem-betamipron and decreases in serum valproic acid concentration. , 1998, Therapeutic drug monitoring.

[30]  D. Fish,et al.  Meropenem, a New Carbapenem Antibiotic , 1997, Pharmacotherapy.

[31]  T. Matsuishi,et al.  Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. , 1997, The Journal of antimicrobial chemotherapy.

[32]  A. Scaloni,et al.  Crystallization and preliminary X-ray studies of human erythrocyte acylpeptide hydrolase. , 1993, Journal of molecular biology.

[33]  T. Baillie,et al.  Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4‐ene‐valproate, a hepatotoxic metabolite of valproic acid , 1990, Clinical pharmacology and therapeutics.

[34]  T. H. Dunning.  Gaussian basis sets for use in correlated molecular calculations. I. The atoms boron through neon and hydrogen , 1989 .

[35]  B. Wilder,et al.  Albumin‐Binding Interactions of Sodium Valproate , 1980, Journal of clinical pharmacology.

[36]  S. Kick,et al.  Valproic Acid-Carbapenem Interaction: Report of Six Cases and a Review of the Literature , 2009, Drug metabolism and drug interactions.

[37]  J. Shimada,et al.  Overview of a new carbapenem, panipenem/betamipron. , 1994, Drugs under experimental and clinical research.

[38]  C. Chuong,et al.  Article type Software , 2007 .